Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Open label extension study to the pivotal efficacy study to assess the safety of sildenafil citrate in patients with pulmonary arterial hypertension
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sildenafil citrate | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Safety | ||
| Standard safety data | ||
| Efficacy | ||
| 6-Minute Walk Test | ||
| BORG Dyspnoea Score | ||
| WHO Functional Class | ||
| Quality of Life SF-36 and EQ-5D |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Birmingham | Alabama | 35233 | United States | ||
| Pfizer Investigational Site |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 22354598 | Derived | Wirostko BM, Tressler C, Hwang LJ, Burgess G, Laties AM. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension. BMJ. 2012 Feb 21;344:e554. doi: 10.1136/bmj.e554. | |
| 21546436 | Derived |
| Label | URL |
|---|---|
| To obtain contact information for a study center near you, click here. | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Birmingham |
| Alabama |
| 35294-0006 |
| United States |
| Pfizer Investigational Site | Birmingham | Alabama | 35294 | United States |
| Pfizer Investigational Site | La Jolla | California | 92037 | United States |
| Pfizer Investigational Site | La Jolla | California | 92093 | United States |
| Pfizer Investigational Site | Los Angeles | California | 90024 | United States |
| Pfizer Investigational Site | Los Angeles | California | 90033 | United States |
| Pfizer Investigational Site | Los Angeles | California | 90073 | United States |
| Pfizer Investigational Site | Los Angeles | California | 90095 | United States |
| Pfizer Investigational Site | San Diego | California | 92103-8320 | United States |
| Pfizer Investigational Site | Torrance | California | 90502 | United States |
| Pfizer Investigational Site | Denver | Colorado | 80220 | United States |
| Pfizer Investigational Site | Denver | Colorado | 80262 | United States |
| Pfizer Investigational Site | Chicago | Illinois | 60637 | United States |
| Pfizer Investigational Site | Baltimore | Maryland | 21287 | United States |
| Pfizer Investigational Site | Boston | Massachusetts | 02111 | United States |
| Pfizer Investigational Site | Ann Arbor | Michigan | 48109 | United States |
| Pfizer Investigational Site | Rochester | Minnesota | 55905 | United States |
| Pfizer Investigational Site | New York | New York | 10032 | United States |
| Pfizer Investigational Site | Durham | North Carolina | 27710 | United States |
| Pfizer Investigational Site | Nashville | Tennessee | 37232-5735 | United States |
| Pfizer Investigational Site | Nashville | Tennessee | 37232 | United States |
| Pfizer Investigational Site | Houston | Texas | 77030 | United States |
| Pfizer Investigational Site | Milwaukee | Wisconsin | 53215 | United States |
| Pfizer Investigational Site | Darlinghurst | New South Wales | 2010 | Australia |
| Pfizer Investigational Site | Melbourne | Victoria | 3004 | Australia |
| Pfizer Investigational Site | Brussels | 1070 | Belgium |
| Pfizer Investigational Site | Leuven | 3000 | Belgium |
| Pfizer Investigational Site | São Paulo | São Paulo | 05403-900 | Brazil |
| Pfizer Investigational Site | Prague | 140 00 | Czechia |
| Pfizer Investigational Site | Prague | 140 21 | Czechia |
| Pfizer Investigational Site | Copenhagen | 2100 | Denmark |
| Pfizer Investigational Site | Clamart | 92141 | France |
| Pfizer Investigational Site | Giessen | 35392 | Germany |
| Pfizer Investigational Site | Hanover | 30625 | Germany |
| Pfizer Investigational Site | Leipzig | 04103 | Germany |
| Pfizer Investigational Site | Shatin NT | Hong Kong |
| Pfizer Investigational Site | Budapest | 1529 | Hungary |
| Pfizer Investigational Site | Zalaegerszeg | 8900 | Hungary |
| Pfizer Investigational Site | Petah Tikva | 49100 | Israel |
| Pfizer Investigational Site | Tel Litwinsky | 52621 | Israel |
| Pfizer Investigational Site | Bologna | 40138 | Italy |
| Pfizer Investigational Site | Pisa | 56124 | Italy |
| Pfizer Investigational Site | Pisa | 56126 | Italy |
| Pfizer Investigational Site | Kuala Lumpur | 59100 | Malaysia |
| Pfizer Investigational Site | Petaling Jaya | 46200 | Malaysia |
| Pfizer Investigational Site | Tlalpan Mexico | Mexico City | 14050 | Mexico |
| Pfizer Investigational Site | Tlalpan | Mexico DF | 14080 | Mexico |
| Pfizer Investigational Site | Amsterdam | 1081 HV | Netherlands |
| Pfizer Investigational Site | Warsaw | 01-138 | Poland |
| Pfizer Investigational Site | Zabrze | 41-800 | Poland |
| Pfizer Investigational Site | Singapore | 168752 | Singapore |
| Pfizer Investigational Site | Parow | Western Cape | 7505 | South Africa |
| Pfizer Investigational Site | Parktown | 2193 | South Africa |
| Pfizer Investigational Site | Parktown West | 2193 | South Africa |
| Pfizer Investigational Site | Suwon | 443-721 | South Korea |
| Pfizer Investigational Site | Barcelona | 08035 | Spain |
| Pfizer Investigational Site | Barcelona | 08036 | Spain |
| Pfizer Investigational Site | Madrid | 28041 | Spain |
| Pfizer Investigational Site | Gothenburg | 41345 | Sweden |
| Pfizer Investigational Site | Papworth Everard | Cambridgeshire | CB3 8RE | United Kingdom |
| Pfizer Investigational Site | Sheffield | South Yorkshire | S10 2JF | United Kingdom |
| Pfizer Investigational Site | Newcastle upon Tyne | Tyne and Wear | NE7 7DN | United Kingdom |
| Pfizer Investigational Site | Cambridge | CB4 9EL | United Kingdom |
| Pfizer Investigational Site | Glasgow | G11 6NT | United Kingdom |
| Rubin LJ, Badesch DB, Fleming TR, Galie N, Simonneau G, Ghofrani HA, Oakes M, Layton G, Serdarevic-Pehar M, McLaughlin VV, Barst RJ; SUPER-2 Study Group. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study. Chest. 2011 Nov;140(5):1274-1283. doi: 10.1378/chest.10-0969. Epub 2011 May 5. |
| ID | Term |
|---|---|
| D006976 | Hypertension, Pulmonary |
| ID | Term |
|---|---|
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D006973 | Hypertension |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000068677 | Sildenafil Citrate |
| ID | Term |
|---|---|
| D013449 | Sulfonamides |
| D000577 | Amides |
| D009930 | Organic Chemicals |
| D013450 | Sulfones |
| D013457 | Sulfur Compounds |
| D010879 | Piperazines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D011687 | Purines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
Not provided
Not provided